冻龄从卵巢开始！胎盘多肽内源性赋能定制女性黄金抗衰曲线

Group 1 - The article highlights the increasing issue of ovarian aging among women, which leads to emotional instability, skin laxity, and other health concerns, prompting a need for interventions in regenerative medicine [1][2] - Research published in Nature Aging reveals significant reductions in key components of ovarian follicles in aging ovaries, including granulosa and theca cells, along with increased expression of apoptosis-related genes [1][3] - The study indicates that aging alters the cellular structure of human ovaries, affecting communication between oocytes and somatic cells, which may lead to follicular dysfunction and ovarian fibrosis [3] Group 2 - The article discusses the shift in the medical aesthetics industry from passive responses to aging to proactive prevention, emphasizing the role of endogenous anti-aging products in promoting cellular regeneration and improving ovarian function [2] - Placental peptides, derived from human placentas, contain over 400 active cell factors and are the only NMPA-approved intravenous human placental products, showing promise in regulating hormone levels and alleviating symptoms related to ovarian aging [4] - Clinical studies suggest that placental peptides can improve women's hormonal balance and address symptoms such as reduced menstrual flow and emotional instability, providing a new avenue for enhancing women's quality of life [4]